Cairn Investment Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
VCM
VPM
Cairn Investment Group's EW Position: Q1 2026 in Review
Cairn Investment Group held its Edwards Lifesciences (EW) position steady in Q1 2026 at 17,800 shares worth $1.43M. The position accounts for 0.71% of the portfolio, ranked #35.
Cairn Investment Group first reported a position in EW in Q4 2019 and has held it in 26 quarters since. The position peaked at $2.85M in Q1 2022. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Cairn Investment Group held 17,800 shares of Edwards Lifesciences worth $1.43M as of Q1 2026.
- Cairn Investment Group left its Edwards Lifesciences share count unchanged in Q1 2026.
- Edwards Lifesciences made up 0.71% of Cairn Investment Group's portfolio in Q1 2026, its #35 holding.
- Cairn Investment Group first reported a position in Edwards Lifesciences in Q4 2019 and has held it in 26 quarters since.
- Cairn Investment Group's Edwards Lifesciences position peaked at $2.85M in Q1 2022.
- 1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Cairn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.